ISDA

Deposition Date 2009-02-03

Release Date 2009-05-19

Last Version Date 2024-10-09

Entry Detail

PDB ID:

3G42

Keywords:

HYDROLASE

Title:

Crystal Structure of TACE with Tryptophan Sulfonamide Derivative Inhibitor

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Cricetulus griseus

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.10 Å

R-Value Free:

0.25

R-Value Work:

0.21

Space Group:

C 1 2 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:ADAM 17
Gene (Uniprot):ADAM17
Mutations:S266A, N452Q
Chain IDs:A, B, C, D
Chain Length:288
Number of Molecules:4
Biological Source:Homo sapiens

UniProt ID:P78536 Pfam ID:PF13688 EC:3.4.24.86

Ligand Molecules

792

Primary Citation

Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-alpha converting enzyme (TACE) inhibitors.

Park, K, Gopalsamy, A, Aplasca, A, Ellingboe, J.W, Xu, W, Zhang, Y, Levin, J.I.Show

Bioorg.Med.Chem. 17 3857 3865 (2009)

PMID: 19410464 DOI: 10.1016/j.bmc.2009.04.033

Abstact

A novel series of non-hydroxamate tryptophan sulfonamide derivatives containing a butynyloxy P1' moiety was identified as inhibitors of TNF-alpha converting enzyme (TACE). The structure-activity relationship of the series was examined via substitution on the tryptophan indole ring. Of the compounds investigated, 2-(4-(but-2-ynyloxy)phenylsulfonamido)-3-(1-(4-methoxybenzyl)-1H-indol-3-yl)propanoic acid (12p) has the best in vitro potency against isolated TACE enzyme with an IC(50) of 80 nM. Compound 12p also shows good selectivity over MMP-1, -13, -14.

Legend

Protein

Chemical

Disease

Primary Citation of related structures